These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 5654674)

  • 1. Chronic oral treatment with disulfiram on dopamine-beta-hydroxylase and biogenic amines.
    Lippmann W
    Eur J Pharmacol; 1968 Apr; 3(1):84-6. PubMed ID: 5654674
    [No Abstract]   [Full Text] [Related]  

  • 2. Dopamine- -hydroxylase inhibition by dimethyldithiocarbamate and related compounds.
    Lippmann W; Lloyd K
    Biochem Pharmacol; 1969 Oct; 18(10):2507-16. PubMed ID: 5403987
    [No Abstract]   [Full Text] [Related]  

  • 3. Metabolism of catecholamines in cold-exposed rats.
    Gibson S; McGeer EG; McGeer PL
    J Neurochem; 1969 Oct; 16(10):1491-3. PubMed ID: 5380009
    [No Abstract]   [Full Text] [Related]  

  • 4. The mechanism of tissue norepinephrine depletion by alpha, alpha'-dipyridyl.
    Bapna J; Neff NH; Costa E
    Neuropharmacology; 1970 Jul; 9(4):333-40. PubMed ID: 5456579
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of oudenone on adrenal tyrosine hydroxylase activity in vivo and on tissue catecholamine concentrations.
    Nagatsu T; Nagatsu I; Umezawa H; Takeuchi T
    Biochem Pharmacol; 1971 Sep; 20(9):2505-7. PubMed ID: 4147779
    [No Abstract]   [Full Text] [Related]  

  • 6. Phenylethyldithiocarbamate: a new dopamine-beta-hydroxylase inhibitor.
    Jonsson J; Grobecker H; Gunne LM
    J Pharm Pharmacol; 1967 Mar; 19(3):201-3. PubMed ID: 4382347
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of disulfiram on the biosynthesis of catecholamines during exposure of rats to cold.
    Goldstein M; Nakajima K
    Life Sci; 1966 Jan; 5(2):175-9. PubMed ID: 5942054
    [No Abstract]   [Full Text] [Related]  

  • 8. In vivo inhibition of dopamine beta-hydroxylase by 1-phenyl-3-(2-thiazolyl)-2-thiourea (U-14,624).
    Johnson GA; Boukma SJ; Kim EG
    J Pharmacol Exp Ther; 1970 Jan; 171(1):80-7. PubMed ID: 5410940
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibition of dopamine-beta-hydroxylase by disulfiram in vivo.
    Musacchio JM; Goldstein M; Anagnoste B; Poch G; Kopin IJ
    J Pharmacol Exp Ther; 1966 Apr; 152(1):56-61. PubMed ID: 5937402
    [No Abstract]   [Full Text] [Related]  

  • 10. Tyrosine hydroxylase inhibition in vitro and in vivo by chelating agents.
    Taylor RJ; Stubbs CS; Ellenbogen L
    Biochem Pharmacol; 1969 Mar; 18(3):587-94. PubMed ID: 5772589
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of stimulation on the levels of tyrosine hydroxylase, dopamine beta-hydroxylase, and catecholamines in intact and denervated rat adrenal glands.
    Patrick RL; Kirshner N
    Mol Pharmacol; 1971 Jan; 7(1):87-96. PubMed ID: 5552254
    [No Abstract]   [Full Text] [Related]  

  • 12. Adrenal tyrosine hydroxylase and dopamine beta-hydroxylase in spontaneously hypertensive rats.
    Nagatsu I; Nagatsu T; Mizutani K; Umezawa H; Matsuzaki M; Takeuchi T
    Nature; 1971 Apr; 230(5293):381-2. PubMed ID: 4927727
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition by disulfiram of the accelerated turnover of catecholamines in the adrenal glands of exercised rats.
    Fuller RW; Snoddy H
    J Pharm Pharmacol; 1968 Feb; 20(2):156-7. PubMed ID: 4384544
    [No Abstract]   [Full Text] [Related]  

  • 14. Dopamine-beta-hydroxylase activity in the rat after hypophysectomy.
    Weinshilboum R; Axelrod J
    Endocrinology; 1970 Nov; 87(5):894-9. PubMed ID: 4320638
    [No Abstract]   [Full Text] [Related]  

  • 15. Adrenal tyrosine hydroxylase: compensatory increase in activity after chemical sympathectomy.
    Mueller RA; Thoenen H; Axelrod J
    Science; 1969 Jan; 163(3866):468-9. PubMed ID: 5762395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Some data on the pathways of interaction of corticosteroids and catecholamines].
    Ruchkina AS
    Ukr Biokhim Zh; 1967; 39(1):96-101. PubMed ID: 5603052
    [No Abstract]   [Full Text] [Related]  

  • 17. Quantitative aspects of the replacement of norepinephrine by dopamine as a sympathetic transmitter after inhibition of dopamine-beta-hydroxylase by disulfiram.
    Thoenen H; Haefely W; Gey KF; Huerlimann A
    J Pharmacol Exp Ther; 1967 May; 156(2):246-51. PubMed ID: 6026255
    [No Abstract]   [Full Text] [Related]  

  • 18. Differentiation of disulfiram effects on central catecholamines and hepatic ethanol metabolism.
    Karamanakos PN; Pappas P; Stephanou P; Marselos M
    Pharmacol Toxicol; 2001 Feb; 88(2):106-10. PubMed ID: 11169169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of secretion from the adrenal medulla. VI. Effect of reserpine on the dopamine -hydroxylase and catecholamine content and on the buoyant density of adrenal storage vesicles.
    Viveros OH; Arqueros L; Kirshner N
    Mol Pharmacol; 1971 Jul; 7(4):434-43. PubMed ID: 5113236
    [No Abstract]   [Full Text] [Related]  

  • 20. Liberation of alpha-methyldopamine as a "false" sympathetic transmitter after pretreatment of cats with alpha-methyldopa and disulfiram.
    Thoenen H; Haefely W; Gey KF; Hürlmann A
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 258(2):181-96. PubMed ID: 4385111
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.